Goldsmith Bruce A 4
4 · ALLOS THERAPEUTICS INC · Filed Feb 27, 2012
Insider Transaction Report
Form 4
Goldsmith Bruce A
VP, Corporate Development
Transactions
- Sale
Common Stock
2012-02-23$1.58/sh−2,500$3,958→ 176,759 total - Sale
Common Stock
2012-02-24$1.54/sh−575$888→ 176,184 total
Footnotes (2)
- [F1]These shares are being sold pursuant to a 10b5-1 plan for Bruce A. Goldsmith in order to cover the withholding tax and other costs associated with such sale (i.e., wire fees, commission or interest) in connection with the vesting of restricted stock units on February 22, 2012.
- [F2]These shares are being sold pursuant to a 10b5-1 plan for Bruce A. Goldsmith in order to cover the withholding tax and other costs associated with such sale (i.e., wire fees, commission or interest) in connection with the vesting of restricted stock units on February 23, 2012.